New study reveals way to predict side-effect risk from common immune suppressant medication: A major new study has found a method to identify people who may experience blood, kidney, or liver related side-effects from methotrexate, the most commonly used immune-suppressing medicine with 1.3 million users in the UK. The method, known as ‘risk stratification’, predicts […]
Read More… from Risk satisfaction to predict abnormal blood results
Interrupting treatment of immune-suppressing medicines, doubles antibody response to COVID-19 booster vaccination: A major clinical trial, led by experts at the University of Nottingham working in partnership with several Universities and NHS hospitals, has found that by interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster […]
Read More… from Immune-suppressing drugs and booster vaccination